Results 1 to 10 of about 48,299 (277)
Stent-induced hypersensitivity leading to refractory in-stent restenosis: a case report [PDF]
Journal of Medical Case ReportsBackground Even in the era of new-generation drug-eluting stents, in-stent restenosis remains a common and challenging problem of percutaneous coronary intervention.
Menghuai Ma, Jiong Tang
doaj +2 more sources
Viabahn for femoropopliteal in-stent restenosis
Annals of Saudi Medicine, 2012 BACKGROUND AND OBJECTIVES: In-stent restenosis in the femoropopliteal artery is common (20%-40%). Treatment of in-stent restenosis is challenged by poor patency rate.
Owayed Al Shammeri +3 more
doaj +4 more sources
Restenosis of Endovascular Stents From Stent Compression
Journal of the American College of Cardiology, 1997 We sought to determine the basis for restenosis within superficial femoral arteries (SFAs) and hemodialysis conduits treated with balloon-expandable stents.Use of stents within coronary and peripheral vessels continues to increase exponentially. The mechanism of restenosis within stents placed at various vascular sites is not well understood.
Laura Haley +4 more
openaire +3 more sources
Current Management of In-Stent Restenosis. [PDF]
J Clin MedIn-stent restenosis (ISR) remains the primary cause of target lesion failure following percutaneous coronary intervention (PCI), resulting in 10-year incidences of target lesion revascularization at a rate of approximately 20%. The treatment of ISR is challenging due to its inherent propensity for recurrence and varying susceptibility to available ...
Giacoppo D, Mazzone PM, Capodanno D.
europepmc +3 more sources
Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review [PDF]
Zhongguo quanke yixue, 2023 As a major treatment for coronary artery disease, percutaneous coronary intervention (PCI) effectively enhances the survival rate of patients. However, the post-PCI in-stent restenosis has become a new cardiovascular problem that is difficult to solve ...
AN Jingjing, WANG Xiaojuan, DENG Aiyun
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 PurposeAs a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients ...
Qiang Feng +5 more
doaj +1 more source
Cardiovascular Therapeutics, 2010 The introduction of coronary stents marked a major turning point in the practice of interventional cardiology. Whereas the efficacy of balloon angioplasty was challenged both by immediate mechanical complications and by a high incidence of restenosis, coronary stents offered cardiologists a means by which to not only augment immediate procedural ...
Michael S. Kim, Larry S. Dean
openaire +3 more sources
Pathogenetic mechanisms of repeated adverse cardiovascular events development in patients with coronary heart disease: the role of chronic inflammation [PDF]
Folia Medica, 2023 Stent restenosis is the most unfavorable complication of interventional treatment for coronary heart disease. We already know from various literature sources that the causes for stent restenosis in patients are both mechanical damage (partial opening ...
Irina Starodubtseva +2 more
doaj +3 more sources
Predictors of In-Stent Restenosis [PDF]
Angiology, 2018 Abstract Not ...
Mehmet Kadri Akboga, Samet Yilmaz
openaire +4 more sources
BMC Neurology, 2023 Background Prognosis after vertebrobasilar stenting (VBS) may differ from that after carotid artery stenting (CAS). Here, we directly compared the incidence and predictors of in-stent restenosis and stented-territory infarction after VBS and compared ...
Jae-Chan Ryu +10 more
doaj +1 more source